HAIKOU, China, March 27, 2017 /PRNewswire/ -- China Pharma
Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT
listed corporation with its fully-integrated specialty
pharmaceuticals subsidiary based in China, today announced that it plans to hold
its fiscal year 2016 earnings conference call on Friday, March 31, 2017 at 8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or
65-671-350-90 for international callers, Conference ID #
90824357. A replay of the call will be accessible through
April 8, 2017 by dialing
1-855-452-5696 or 61-281-990-299 for international callers,
Conference ID # 90824357.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical
company that develops, manufactures and markets a diversified
portfolio of products focused on conditions with a high incidence
and high mortality rates in China,
including cardiovascular, CNS, infectious, and digestive diseases.
The Company's cost-effective business model is driven by market
demand and supported by new GMP-certified product lines covering
the major dosage forms. In addition, the Company has a broad and
expanding nationwide distribution network across all major cities
and provinces in China. The
Company's wholly-owned subsidiary, Hainan Helpson Medical &
Biotechnology Co., Ltd., is located in Haikou City, Hainan
Province. For more information about China Pharma Holdings,
Inc., please visit http://www.chinapharmaholdings.com. The Company
routinely posts important information on its website.
Diana Na Huang, CFA
BOD Secretary & IR Manager
China Pharma Holdings, Inc.
Tel: 86-898-66811730
Fax: 86-898-66819024
E-mail: hps@chinapharmaholdings.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cphi-to-hold-fiscal-year-2016-earnings-conference-call-on-friday-march-31-2017-at-830-am-et-300429514.html
SOURCE China Pharma Holdings, Inc.